Panacea Life Sciences Holdings, Inc.: 10-Q filed 2016-11-14

Name: Panacea Life Sciences Holdings, Inc.: 10-Q filed 2016-11-14
Creator: Panacea Life Sciences Holdings, Inc.

What Panacea Life Sciences Holdings, Inc. reported in its quarterly report filed 2016-11-14 (fiscal Q3 2016): 32 published measures, 85 facts as tagged in accession 0001415889-16-007400.

This filing

Form: 10-Q (quarterly report)
Filed: 2016-11-14
Fiscal period: fiscal Q3 2016
Accession: 0001415889-16-007400 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All Panacea Life Sciences Holdings, Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

Period	Value	Unit	Days
At 2016-09-30	1,084,494	USD
At 2015-12-31	84,885	USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

Period	Value	Unit	Days
At 2016-09-30	437,029	USD
At 2015-12-31	178,205	USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

Period	Value	Unit	Days
At 2016-09-30	647,465	USD
At 2015-12-31	-93,320	USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

Period	Value	Unit
At 2016-09-30	34,494	USD
At 2015-12-31	0	USD
At 2015-09-30	11,710	USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-359,813	USD	92
2016-01-01 to 2016-09-30	-855,507	USD	274
2015-01-01 to 2015-09-30	-329,617	USD	273
2015-04-01 to 2015-06-30	-112,628	USD	91

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-484,140	USD	274
2015-01-01 to 2015-09-30	-570,878	USD	273

Capital expenditure payments

Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	-1,292	USD	274
2015-01-01 to 2015-09-30	0	USD	273

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

Period	Unit	Days
2016-07-01 to 2016-09-30	USD	92
2016-01-01 to 2016-09-30	USD	274
2015-01-01 to 2015-09-30	USD	273
2015-04-01 to 2015-06-30	USD	91

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	445,000	USD	274
2015-01-01 to 2015-09-30	540,896	USD	273

Investing cash flow

Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	1,292	USD	274
2015-01-01 to 2015-09-30	0	USD	273

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

Period	Value	Unit	Days
At 2016-09-30	-1,592,466	USD
At 2015-12-31	-736,959	USD

Net property, plant and equipment

Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.

Period	Value	Unit	Days
At 2016-09-30	0	USD
At 2015-12-31	1,453	USD

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-359,813	USD	92
2016-01-01 to 2016-09-30	-854,054	USD	274
2015-01-01 to 2015-09-30	-319,630	USD	273
2015-04-01 to 2015-06-30	-102,428	USD	91

Current assets

Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.

Period	Value	Unit	Days
At 2016-09-30	1,034,494	USD
At 2015-12-31	79,352	USD

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

Period	Value	Unit	Days
At 2016-09-30	437,029	USD
At 2015-12-31	178,205	USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

Period	Value	Unit	Days
At 2016-09-30	405,875	USD
At 2015-12-31	75,483	USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	359,813	USD	92
2016-01-01 to 2016-09-30	854,054	USD	274
2015-01-01 to 2015-09-30	319,630	USD	273
2015-04-01 to 2015-06-30	102,428	USD	91

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	97,244	USD	92
2016-01-01 to 2016-09-30	216,644	USD	274
2015-01-01 to 2015-09-30	77,344	USD	273
2015-04-01 to 2015-06-30	25,079	USD	91

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

Period	Value	Unit	Days
At 2016-09-30	33,430,018	shares
At 2015-12-31	515,290	shares

Additional paid-in capital

Capital contributed above par value under this concept. It records historical contributions, not the current value of the equity or cash on hand.

Period	Value	Unit	Days
At 2016-09-30	2,235,877	USD
At 2015-12-31	643,587	USD

Accumulated depreciation on property, plant and equipment

Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.

Period	Value	Unit	Days
At 2016-09-30	0	USD
At 2015-12-31	1,914	USD

Net intangible assets excluding goodwill

Intangible assets other than goodwill after amortization and impairment. Internally developed intangibles are usually not recognized, so this understates what a company relies on.

Period	Value	Unit	Days
At 2016-09-30	0	USD
At 2015-12-31	4,080	USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

Period	Value	Unit	Days
At 2016-09-30	31,154	USD
At 2015-12-31	1,550	USD

Pre-tax income or loss from continuing operations

Income or loss from continuing operations before income taxes and noncontrolling interests. It excludes discontinued operations and is not net income.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-359,813	USD	92
2016-01-01 to 2016-09-30	-855,507	USD	274
2015-01-01 to 2015-09-30	-329,830	USD	273
2015-04-01 to 2015-06-30	-112,628	USD	91

Comprehensive income or loss

Net income plus other comprehensive income after tax. It includes unrealized items that net income excludes and is not a cash measure.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	-359,813	USD	92
2016-01-01 to 2016-09-30	-855,507	USD	274
2015-01-01 to 2015-09-30	-329,617	USD	273
2015-04-01 to 2015-06-30	-112,113	USD	91

General and administrative expense

General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	142,573	USD	92
2016-01-01 to 2016-09-30	378,650	USD	274
2015-01-01 to 2015-09-30	91,126	USD	273
2015-04-01 to 2015-06-30	31,353	USD	91

Other nonoperating income or expense

Other income or expense outside operations under this concept. The composition is filer-specific and can include one-time items.

Period	Value	Unit	Days
2016-07-01 to 2016-09-30	0	USD	92
2016-01-01 to 2016-09-30	-1,453	USD	274
2015-01-01 to 2015-09-30	-10,200	USD	273
2015-04-01 to 2015-06-30	-10,200	USD	91

Current income tax expense or benefit

Income tax expense or benefit for the period that is currently payable or refundable. It differs from cash taxes paid and from total tax expense.

Period	Unit	Days
2016-07-01 to 2016-09-30	USD	92
2016-01-01 to 2016-09-30	USD	274
2015-01-01 to 2015-09-30	USD	273
2015-04-01 to 2015-06-30	USD	91

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	0	USD	274
2015-01-01 to 2015-09-30	0	USD	273

Income taxes paid, net

Cash income taxes paid net of refunds during the period. It differs from income tax expense and can reflect prior years and estimated payments.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	0	USD	274
2015-01-01 to 2015-09-30	0	USD	273

Change in accounts receivable

The cash flow adjustment for the change in receivables during the period. A positive value under this concept means receivables grew and reduced operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	0	USD	274
2015-01-01 to 2015-09-30	-213	USD	273

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

Period	Value	Unit	Days
2016-01-01 to 2016-09-30	330,392	USD	274
2015-01-01 to 2015-09-30	62,777	USD	273

Inspect the source

Entity: Panacea Life Sciences Holdings, Inc. / CIK 0001552189
Captured: 2026-09-20T09:18:48.131Z
SEC response SHA-256: ab0fb9e968655e139f69554f75636a16ed20b7f4fdbb18db5bb98dd1523ff07d

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python

import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001552189.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))